Published Online: Friday, September 1, 2006

The American Society of Consultant Pharmacists (ASCP) recently addressed medication therapy management services (MTMS) in long-term care. MTMS programs are expected to (1) optimize therapeutic outcomes through improved medication use; (2) reduce the risk of adverse events, including adverse drug interactions; (3) be conducted by a pharmacist or other qualified health care provider; and (4) differentiate between services in ambulatory and institutional settings.

In its policy statement, ASCP highlighted the following points:

  • ASCP advocates that Part D sponsors provide flexibility in the MTMS offered to patients of long-term care facilities and that these services mirror the unique differences in these residents and settings
  • The MTMS program should mainly focus on optimizing therapeutic outcomes and reducing adverse drug events for the beneficiary, and secondarily focus on reductions of drug costs when necessary
  • Pharmacists who provide MTMS to long-term care facility residents should have expertise in geriatric drug therapy
  • MTMS recommendations received by the administrator, prescriber, pharmacy provider, or caregiver/resident are best reconciled by the facility's consultant pharmacist

Latest Issues